Biocon Limited — Others, 11-08-2025: Shareholders meeting

Biocon shareholders have approved all 18 resolutions at the 47th Annual General Meeting. Key approvals include the adoption of financial results for the year ended March 31, 2025, and re-appointments of Directors Prof. Ravi Mazumdar and Naina Lal Kidwai. A final dividend of Re. 0.50 per equity share (10%) was also declared. Shareholders also approved crucial related party transactions involving various subsidiaries, ensuring continuity in business operations. Additionally, limits for investments and loans were increased, and auditor appointments were ratified, reflecting strong shareholder alignment with the company's governance and operational plans.